TIL Instil Bio, Inc.

NASDAQ
$5.43

Instil Bio, Inc. (TIL) is expected to report earnings on February 15, 2027, after the market close.

Instil Bio Reported Earnings
Monday, November 16, 2026 · 7:00 AM ET
Earnings Date
Feb 15
Monday · 5:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Instil Bio, Inc.

Instil Bio Inc. is a clinical-stage biopharmaceutical company. It is focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer. Instil Bio Inc. is based in DALLAS.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.